Business Context and Reporting Period
Seastar Medical Holding Corp (NASDAQ: ICU), an emerging growth company, filed this Form 8-K on January 12, 2024, to report an "Other Event" under Item 8.01. The filing details the completion of an Additional Closing under a Securities Purchase Agreement (SPA) originally dated March 15, 2023, and amended on December 11, 2023, with an institutional investor.
Key Financial Metrics and Transaction Details
This filing reports a specific financing transaction rather than periodic financial performance metrics. The following capital raise details were disclosed:
- Convertible Note Principal: $271,739.13
- Note Conversion Price: $0.56 per share
- Warrants Issued: Two separate warrants, each for up to 131,927 shares of Common Stock (Total: 263,854 shares)
- Warrant Exercise Price: $0.56 per share
- Conversion Start Date: June 11, 2024, or earlier upon mutual agreement or an Event of Default
The filing text does not provide clear values for revenue, profit, cash flow, margins, total debt, or liquidity positions as this is a current report on a specific event, not a periodic financial statement.
Material Changes and Transaction Terms
The material change reported is the issuance of additional debt and equity instruments to the Purchaser. This transaction continues the funding arrangement established in prior closings reported in 8-K filings from March, August, September, November, and December 2023. The new instruments carry a conversion/exercise price of $0.56, which is consistent with the terms of the Second Amendment to the SPA.
Outlook, Risks, and Management Commentary
Management commentary is limited to the confirmation of the transaction's completion. The filing references prior 8-K filings for comprehensive terms regarding the SPA, Notes, and Warrants. No specific forward-looking guidance, risk factors, or contingencies were introduced in this specific document beyond the standard terms of the convertible note (e.g., conversion upon an Event of Default).
Investor Verification Checklist
- Verify the total aggregate principal amount of all Notes issued under the SPA to date.
- Confirm the total number of shares underlying all outstanding warrants issued under the SPA.
- Review the "Event of Default" definitions in the Note to understand potential acceleration triggers.
- Check the company's most recent 10-K or 10-Q for updated liquidity and cash position following this capital raise.
- Confirm the current trading price of the Common Stock relative to the $0.56 conversion and exercise price.